Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02342782
Title	Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	City of Hope Medical Center
Indications	mature T-cell and NK-cell lymphoma
Therapies	Carmustine + Cytarabine + Etoposide + Melphalan + Yttrium Y 90 Basiliximab
Age Groups:	adult
Covered Countries	USA